Skip to search formSkip to main contentSkip to account menu

ramelteon

Known as: (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide, ramelteon [Chemical/Ingredient] 
A synthetic melatonin analogue with hypnotic and circadian rhythm-modulating activities. Ramelteon binds to and activates melatonin receptors 1 and 2… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (1)

Indenes
Ramelteon M-II:MCnt:Pt:Tiss:QnRamelteon:MCnc:Pt:Ser/Plas:Qnramelteon 8 MG Oral Tablet [Rozerem]

Narrower (2)

RozeremTAK-375

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial
Background Insomnia is associated with the onset and development of diabetes. Melatonin affects sleep quality and glucose… 
2015
2015
Pharmacological Treatment of Insomnia.
Up to 70 million U.S. adults have chronic sleep and wakefulness disorders. Therapies may include prescription medications… 
2014
2014
The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
Children with autism spectrum disorders (ASD), including autistic disorder, frequently suffer from comorbid sleep problems. An… 
2012
2012
Marked improvement in delirium with ramelteon: five case reports
Delirium is a common and serious acute neuropsychiatric syndrome characterized by inattention and global cognitive dysfunction… 
2011
2011
Placebo-Controlled Pilot Study of Ramelteon for Adiposity and Lipids in Patients With Schizophrenia
Objective: Few interventions have been successful to prevent or reverse the medical complications associated with antipsychotic… 
2011
2011
Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
2009
2009
Health before profits? Learning from Thailand's experience
Review
2007
Review
2007
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
OBJECTIVE From a safety perspective, several issues require assessment when a decision is made to prescribe a sleep medication… 
Review
2007
Review
2007
New perspectives for the treatment of disorders of sleep and arousal.
2006
2006
Ramelteon (Rozerem) for insomnia.
Ramelteon is safe and effective for decreasing the time to persistent sleep in patients with chronic insomnia. It does not have… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)